FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385060002: Prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636019019 Extended-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
50021051000188114 comprimé oral à libération prolongée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet Is a A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Prolonged-release oral tablet Is a Oral tablet false Inferred relationship Some
Prolonged-release oral tablet Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. true Inferred relationship Some
Prolonged-release oral tablet Is a Modified-release oral tablet (dose form) true Inferred relationship Some
Prolonged-release oral tablet Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. true Inferred relationship Some
Prolonged-release oral tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release oral tablet Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release oral tablet Has basic dose form (attribute) A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely ranolazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Tacrolimus 4 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Tacrolimus 750 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paracetamol 1 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Isosorbide mononitrate 30 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Aciclovir 1.2 g prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Nicotinic acid 375 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely finasteride 5 milligram and tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely zolpidem tartrate 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Piribedil 50 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carvedilol phosphate 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carvedilol phosphate 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Ambroxol acefyllinate 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Aceclofenac 200 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely lamotrigine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 200 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 300 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 250 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Alprazolam 1 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Alprazolam 500 microgram prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Amisulpride 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Prazosin (as prazosin hydrochloride) 5 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely lornoxicam 16 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Fostemsavir (as fostemsavir trometamol) 600 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Cefaclor 500 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely upadacitinib 30 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some

Start Previous Page 4 of 4

This concept is not in any reference sets

Back to Start